Tenax Therapeutics (TENX) Posts Q2 Loss of 14c/Share

Tenax Therapeutics (NASDAQ: TENX) reported Q2 EPS of ($0.14), $0.04 better than the analyst estimate of ($0.18).

For earnings history and earnings-related data on Tenax Therapeutics (TENX) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• Freedom Broker Starts Unity Bancorp (UNTY) at Hold
• Bending Spoons closes IPO, raises ~$954M on Nasdaq